These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15110237)

  • 1. 5th International symposium on IVIG: IVIG in the third millenium, 25-27 September 2003, Interlaken, Switzerland.
    Shoenfeld Y
    Autoimmun Rev; 2004 Mar; 3(3):234-41. PubMed ID: 15110237
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of severe muscle necrosis with intravenous immunoglobulin.
    McRorie E; King M; Richmond R; Smith G; Jobanputra P; Nuki G
    J Rheumatol; 1999 Jun; 26(6):1411-3. PubMed ID: 10381067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis.
    Katz-Agranov N; Khattri S; Zandman-Goddard G
    Autoimmun Rev; 2015 Aug; 14(8):651-8. PubMed ID: 25870941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can we do without intravenous polyclonal immunoglobines (IVIg)?].
    Gary-Crosier F; Nydegger U; Villard J
    Rev Med Suisse; 2009 Apr; 5(199):819-22. PubMed ID: 19441747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin treatment in autoimmune neurological disorders--effects on quality of life.
    Padua L; Sabatelli M; Evoli A; Pazzaglia C; Tonali P
    Hum Immunol; 2005 Apr; 66(4):417-21. PubMed ID: 15866706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
    Katz U; Kishner I; Magalashvili D; Shoenfeld Y; Achiron A
    Autoimmunity; 2006 Sep; 39(6):513-7. PubMed ID: 17060031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E; Ito-Ihara T; Ono T; Imai E; Yamagata K; Akamatsu A; Suzuki K
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Symposium on Inborn Errors of Metabolism in Humans, 2-5 September 1980, Interlaken, Switzerland. Work in progress.
    J Inherit Metab Dis; 1981; 4(3):113-76. PubMed ID: 6115955
    [No Abstract]   [Full Text] [Related]  

  • 11. The 6th International Immunoglobulin Symposium, Interlaken, Switzerland, 26-28 March 2009.
    Jolles S; Kaveri SV; Orange J
    Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):1-70. PubMed ID: 19883418
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG).
    Maetzke J; Sperfeld AD; Scharffetter-Kochanek K; Sunderkötter C
    Allergy; 2006 Jan; 61(1):145-6. PubMed ID: 16364173
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous immunoglobulin treatment in autoimmune diseases].
    Danieli MG; Calcabrini L; Marchetti A; Calabrese V; Pettinari L; Massaccesi C; Gabrielli A; Danieli G
    Recenti Prog Med; 2007 Jun; 98(6):322-6. PubMed ID: 17580523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin in neurological disease: a specialist review.
    Wiles CM; Brown P; Chapel H; Guerrini R; Hughes RA; Martin TD; McCrone P; Newsom-Davis J; Palace J; Rees JH; Rose MR; Scolding N; Webster AD
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):440-8. PubMed ID: 11909900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous polyclonal human immunoglobulins in multiple sclerosis.
    Soelberg Sorensen P
    Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.
    Simoes J; Sciascia S; Camara I; Baldovino S; Karim Y; Roccatello D; Cuadrado MJ
    J Clin Rheumatol; 2015 Jan; 21(1):35-7. PubMed ID: 25539433
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients.
    Kreuter A; Gambichler T; Breuckmann F; Bechara FG; Rotterdam S; Stücker M; Altmeyer P
    J Am Acad Dermatol; 2004 Oct; 51(4):574-9. PubMed ID: 15389193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inpatient paediatric use of intravenous immunoglobulin at an academic medical centre.
    Dashti-Khavidaki S; Khalili H; Farshadi F; Aghamohammadi A; Movahedi M; Hajibabaei M
    Singapore Med J; 2008 Feb; 49(2):147-9. PubMed ID: 18301844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.